JP2016523260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523260A5 JP2016523260A5 JP2016521898A JP2016521898A JP2016523260A5 JP 2016523260 A5 JP2016523260 A5 JP 2016523260A5 JP 2016521898 A JP2016521898 A JP 2016521898A JP 2016521898 A JP2016521898 A JP 2016521898A JP 2016523260 A5 JP2016523260 A5 JP 2016523260A5
- Authority
- JP
- Japan
- Prior art keywords
- pruritus
- serlopitant
- octahydroisoindol
- cyclopent
- polymorph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361838784P | 2013-06-24 | 2013-06-24 | |
| US13/925,509 | 2013-06-24 | ||
| US61/838,784 | 2013-06-24 | ||
| US13/925,509 US8906951B1 (en) | 2013-06-24 | 2013-06-24 | Use of NK-1 receptor antagonists in pruritus |
| PCT/US2014/043811 WO2014209962A1 (en) | 2013-06-24 | 2014-06-24 | Use of nk-1 receptor antagonist serlopitant in pruritus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019087897A Division JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016523260A JP2016523260A (ja) | 2016-08-08 |
| JP2016523260A5 true JP2016523260A5 (enExample) | 2017-08-03 |
Family
ID=51230173
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521898A Ceased JP2016523260A (ja) | 2013-06-24 | 2014-06-24 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
| JP2019087897A Pending JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019087897A Pending JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3013336A1 (enExample) |
| JP (2) | JP2016523260A (enExample) |
| KR (1) | KR20160023692A (enExample) |
| CN (1) | CN105473138A (enExample) |
| AU (2) | AU2014302694B2 (enExample) |
| BR (1) | BR112015031724A2 (enExample) |
| CA (1) | CA2915474A1 (enExample) |
| HK (1) | HK1223820A1 (enExample) |
| IL (1) | IL243189A0 (enExample) |
| MX (2) | MX366728B (enExample) |
| PH (2) | PH12015502777A1 (enExample) |
| RU (1) | RU2666219C2 (enExample) |
| WO (1) | WO2014209962A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| WO2016044784A1 (en) | 2014-09-19 | 2016-03-24 | Heron Therapeutics, Inc. | Emulson formulations of aprepitant |
| RU2770050C2 (ru) * | 2015-03-04 | 2022-04-14 | Ванда Фармасьютиклз Инк. | Способ лечения с применением традипитанта |
| US9974742B2 (en) | 2016-02-01 | 2018-05-22 | Heron Therapeutics, Inc. | Emulsion formulations of an NK-1 receptor antagonist and uses thereof |
| KR20180118136A (ko) * | 2016-02-01 | 2018-10-30 | 헤론 테라퓨틱스 인코포레이티드 | Nk-1 수용체 길항제를 포함하는 에멀젼 |
| CN109640981A (zh) * | 2016-06-29 | 2019-04-16 | 曼隆治疗公司 | 神经激肽-1拮抗剂用于治疗多种瘙痒病症的用途 |
| CA3073998A1 (en) * | 2017-09-13 | 2019-03-21 | Vanda Pharmaceuticals Inc. | Improved treatment of atopic dermatitis with tradipitant |
| SG11202003886TA (en) * | 2017-11-01 | 2020-05-28 | Nat Univ Singapore | Use of serotonergic drugs to treat virus-induced thrombocytopenia |
| JP7324210B2 (ja) * | 2018-01-31 | 2023-08-09 | ティダブリューアイ・バイオテクノロジー・インコーポレイテッド | トファシチニブを含む局所製剤 |
| KR20210078515A (ko) | 2018-10-18 | 2021-06-28 | 아비어, 인크. | 만성 신장 질환-연관 소양증의 치료 방법 및 장치 |
| KR20220145844A (ko) | 2020-02-25 | 2022-10-31 | 반다 파마슈티칼즈, 인코퍼레이티드. | 트라디피탄트를 이용한 아토피 피부염의 개선된 치료 |
| CN115015440B (zh) * | 2022-07-08 | 2024-10-15 | 江苏杜瑞制药有限公司 | 一种生物样品中纳呋拉啡的检测方法 |
| CN117503699A (zh) * | 2023-12-08 | 2024-02-06 | 斯坦德医药研发(江苏)有限公司 | 阿瑞匹坦口服液制剂及制剂制造方法 |
| WO2025250635A1 (en) * | 2024-05-28 | 2025-12-04 | Avior, Inc. | Use of nalmefene hydrochloride buccal films in treating liver disease associated pruritus |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030100565A1 (en) | 2001-09-21 | 2003-05-29 | Boehringer Ingelheim International Gmbh | Method for the treatment or prevention of atopic dermatitis |
| TWI341198B (en) | 2004-01-27 | 2011-05-01 | Merck Sharp & Dohme | Hydroisoindoline tachykinin receptor antagonists |
| CN100582093C (zh) * | 2004-01-27 | 2010-01-20 | 默克公司 | 氢异二氢吲哚速激肽受体拮抗剂 |
| JP2009500452A (ja) | 2005-07-11 | 2009-01-08 | メルク エンド カムパニー インコーポレーテッド | ヒドロイソインドリンタキキニン受容体アンタゴニストの製造方法 |
| WO2007044296A2 (en) | 2005-10-04 | 2007-04-19 | Merck & Co., Inc. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| WO2007146224A2 (en) | 2006-06-12 | 2007-12-21 | Merck & Co., Inc. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| JP2010502703A (ja) * | 2006-09-06 | 2010-01-28 | メルク エンド カムパニー インコーポレーテッド | 置換アミドの経口投与のための液体及び半固体の医薬製剤 |
| EP2089019A4 (en) | 2006-11-02 | 2011-05-04 | Merck Sharp & Dohme | POLYMORPHIC OF A HYDROISOINDOLINE TACHYKININE RECEPTOR ANTAGONIST |
| EP2141992A1 (en) | 2007-03-29 | 2010-01-13 | Merck & Co., Inc. | Combination therapy for the treatment-of lower urinary tract symptoms |
| RU2370265C1 (ru) * | 2008-03-04 | 2009-10-20 | Лев Давидович Раснецов | Гель, обладающий противовоспалительным и противоаллергическим действием |
-
2014
- 2014-06-24 CA CA2915474A patent/CA2915474A1/en not_active Abandoned
- 2014-06-24 WO PCT/US2014/043811 patent/WO2014209962A1/en not_active Ceased
- 2014-06-24 AU AU2014302694A patent/AU2014302694B2/en not_active Ceased
- 2014-06-24 RU RU2015154037A patent/RU2666219C2/ru active
- 2014-06-24 KR KR1020157035921A patent/KR20160023692A/ko not_active Ceased
- 2014-06-24 BR BR112015031724A patent/BR112015031724A2/pt not_active Application Discontinuation
- 2014-06-24 EP EP14744671.0A patent/EP3013336A1/en not_active Withdrawn
- 2014-06-24 HK HK16111172.9A patent/HK1223820A1/zh unknown
- 2014-06-24 JP JP2016521898A patent/JP2016523260A/ja not_active Ceased
- 2014-06-24 CN CN201480035219.3A patent/CN105473138A/zh active Pending
- 2014-06-24 MX MX2015017763A patent/MX366728B/es active IP Right Grant
-
2015
- 2015-12-14 PH PH12015502777A patent/PH12015502777A1/en unknown
- 2015-12-17 IL IL243189A patent/IL243189A0/en unknown
- 2015-12-18 MX MX2019008643A patent/MX2019008643A/es unknown
-
2019
- 2019-05-07 JP JP2019087897A patent/JP2019142960A/ja active Pending
-
2020
- 2020-01-14 AU AU2020200259A patent/AU2020200259A1/en not_active Abandoned
- 2020-02-04 PH PH12020500255A patent/PH12020500255A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1127661T1 (el) | Αρυλικες, ετεροαρυλικες και ετεροκυκλικες ενωσεις για τη θεραπευτικη αντιμετωπιση διαταραχων που διαμεσολαβουνται απο το συμπληρωμα | |
| CY2025013I1 (el) | Αρυλικες, ετεροαρυλικες και ετεροκυκλικες ενωσεις για τη θεραπευτικη αντιμετωπιση διαταραχων που διαμεσολαβουνται απο το συμπληρωμα | |
| CY1124669T1 (el) | ΑΝΤΙ-ΟΙΣΤΡΟΓΟΝΙΚΑ ΦΑΡΜΑΚΑ ΤΕΤΡΑΫΔΡΟ-1Η-ΠΥΡΙΔΟ[3,4-b]INΔOΛIOY | |
| JP2016034978A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2013519675A5 (enExample) | ||
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| JP2016515522A5 (enExample) | ||
| JP2016539157A5 (enExample) | ||
| JP2016535795A5 (enExample) | ||
| JP2017035491A5 (ja) | 頭蓋内出血の治療のための方法および装置 | |
| JP2015024998A5 (enExample) | ||
| CY1118839T1 (el) | Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη | |
| EA201591291A1 (ru) | Производные пиримидона и их применение в лечении, облегчении или профилактике вирусного заболевания | |
| JP2013543896A5 (enExample) | ||
| JP2015504870A5 (enExample) | ||
| JP2013173781A5 (enExample) | ||
| JP2015078220A5 (enExample) | ||
| JP2011148799A5 (enExample) | ||
| JP2016522254A5 (enExample) | ||
| MY185516A (en) | Compositions and methods for treating schizophrenia | |
| JP2015199738A5 (enExample) | ||
| JP2015522522A5 (enExample) | ||
| IL263004B (en) | A new crystalline form of n-[5-(5,3-difluoro-benzyl)-h1-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4 -ilamino)-benzamide | |
| IL283823A (en) | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease |